Relief Therapeutics Holding AG (RLFTF)

[Narbooty1]

The annual incidence ranges from 0.22 to 1.57 per 100,000 for cerebral venous thrombosis (the type of clot I see referenced in articles). There is a 3 to 1 ratio in women vs men. The 6 cases that developed cerebral venous thrombosis out of 6.8 million people vaccinated with the J&J vaccine represents a rate of 0.0882 per 100,000. At the moment that is less than than the expected incidence in the general population of non vaccinated people. Hopefully more aggressive investigation does not reveal many more cases, but finding even 100 more could still be in line with expectations in general public. Time will tell. I'm hopeful.